Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03PIB
|
||||
| Former ID |
DNC002721
|
||||
| Drug Name |
Alrestatin
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Discontinued in Phase 2 | [545678] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C14H9NO4
|
||||
| Canonical SMILES |
C1=CC2=C3C(=C1)C(=O)N(C(=O)C3=CC=C2)CC(=O)O
|
||||
| InChI |
1S/C14H9NO4/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19/h1-6H,7H2,(H,16,17)
|
||||
| InChIKey |
GCUCIFQCGJIRNT-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 51411-04-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
147800, 224765, 3226047, 3897132, 7403856, 7885850, 8151438, 11113527, 11121757, 11122237, 11130822, 11132748, 11133320, 11341937, 11362120, 11362898, 11364343, 11365460, 11366905, 11368022, 11369467, 11370987, 11370988, 11372959, 11373497, 11373623, 11376184, 11377629, 11487522, 11491695, 11491904, 11495263, 14995871, 26703033, 26751737, 29221300, 46508635, 46516655, 47589173, 47810955, 48185170, 48185171, 49883441, 50104434, 50104435, 50930601, 53788020, 57321153, 58031693, 81093285
|
||||
| Target and Pathway | |||||
| Target(s) | Aldose reductase | Target Info | Inhibitor | [551393] | |
| NetPath Pathway | IL1 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.